University of Arkansas/Food and Drug Administration Food Labeling; Public Workshop; Correction, 2253 [E6-268]
Download as PDF
Federal Register / Vol. 71, No. 9 / Friday, January 13, 2006 / Notices
2253
before the release of the samples. This
agreement will contain the conditions
for use of the DNA as stated in this
document and as agreed upon by the
investigators and CDC. A key
component of this agreement is that no
attempt will be made to link the results
of the proposed research to any other
data, including, but not limited to, the
NHANES III public use data set. Also,
the investigator agrees that the samples
cannot be used for commercial
purposes. A list of genes generated from
the testing of the NHANES III samples
will be made available to the public for
potential solicitation of proposal for
secondary data analysis, six months
after the data is sent to the RDC. These
secondary data analysis proposals must
also be reviewed by the NHANES
Genetics Technical Panel and the ERB.
2. Clayton EW, Steinberg KK, Khoury
MJ, et al. Informed consent for genetic
research on stored tissue samples.
JAMA 1995;274:1786–1792.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 21, 2005.
James D. Seligman,
Associate Director for Program Services,
Centers for Disease Control and Prevention.
[FR Doc. E5–8104 Filed 1–12–06; 8:45 am]
National Cancer Institute; Notice of
Closed Meeting
Progress Reports
AGENCY:
A progress report will be submitted
annually. CDC/NCHS ERB continuation
reports are also required annually.
HHS.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
University of Arkansas/Food and Drug
Administration Food Labeling; Public
Workshop; Correction
Food and Drug Administration,
Notice of public workshop;
correction.
ACTION:
Disposition of Results and Samples
No DNA samples provided can be
used for any purpose other than those
specifically requested in the proposal
and approved by the Genetics Technical
Panel, the Secondary Review Committee
and the NHANES ERB. No sample can
be shared with others, including other
investigators, unless specified in the
proposal and so approved. Any unused
samples must be destroyed upon
completion of the approved project,
unless a request is submitted and
approved under Category D. Researchers
requesting DNA samples for age-racegender studies and special studies will
be required to provide NCHS with the
results of all DNA tests performed for
each anonymized sample. These results,
once returned to NCHS, will be part of
the public domain. Therefore, ample
time will be given to the investigator to
publish results prior to reporting the
results to NCHS.
Send Requests for Information
hsrobinson on PROD1PC70 with NOTICES
Ms. Kika Oraegbu, Division of Health
and Nutrition Examination Surveys,
National Center for Health Statistics,
Centers for Disease Control and
Prevention, 3311 Toledo Road, Room
4207, Hyattsville, MD 20782, Phone:
301–458–4367, Fax: 301–458–4028, Email: KDO1@cdc.gov.
References
1. Plan and Operation of the Third
National Health and Nutrition
Examination Survey, 1988–94. National
Center for Health Statistics. Vital Health
Stat (32) 1994.
VerDate Aug<31>2005
18:33 Jan 12, 2006
Jkt 208001
SUMMARY: The Food and Drug
Administration (FDA) is correcting a
notice that appeared in the Federal
Register of January 4, 2006 (71 FR 349).
The document announced a public
workshop entitled ‘‘UA/FDA Food
Labeling Workshop.’’ The document
was published with a typographical
error in the SUPPLEMENTARY INFORMATION
section. This document corrects that
error.
FOR FURTHER INFORMATION CONTACT:
David Arvelo, Food and Drug
Administration, 4040 North Central
Expressway, suite 900, Dallas, TX
75204, 214–253–4952, FAX: 214–243–
4970.
In FR Doc.
E5–8225, appearing on page 349, in the
Federal Register of Wednesday, January
4, 2006, the following correction is
made:
1. On page 349, in the third column,
the second sentence under
SUPPLEMENTARY INFORMATION is
corrected to read: ‘‘This public
workshop is being held in response to
the large volume of food labeling
inquiries from small food manufacturers
and startups originating from the area
covered by the FDA Dallas District
Office.’’
SUPPLEMENTARY INFORMATION:
Dated: January 9, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–268 Filed 1–12–06; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Synthesis
and High-Throughput Screening of In Vivo
Cancer Molecular Imaging Agents.
Date: February 24, 2006.
Time: 12 p.m. to 4:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Executive Plaza North, 6130
Executive Boulevard, Room C, Rockville, MD
20852. (Telephone Conference Call).
Contact Person: Kenneth L Bielat, PhD,
Scientific Review Administrator, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, Room 7147, Bethesda,
MD 20892. (301) 496–7576.
bielatk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 5, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–303 Filed 1–12–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\13JAN1.SGM
13JAN1
Agencies
[Federal Register Volume 71, Number 9 (Friday, January 13, 2006)]
[Notices]
[Page 2253]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-268]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
University of Arkansas/Food and Drug Administration Food
Labeling; Public Workshop; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public workshop; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a notice
that appeared in the Federal Register of January 4, 2006 (71 FR 349).
The document announced a public workshop entitled ``UA/FDA Food
Labeling Workshop.'' The document was published with a typographical
error in the SUPPLEMENTARY INFORMATION section. This document corrects
that error.
FOR FURTHER INFORMATION CONTACT: David Arvelo, Food and Drug
Administration, 4040 North Central Expressway, suite 900, Dallas, TX
75204, 214-253-4952, FAX: 214-243-4970.
SUPPLEMENTARY INFORMATION: In FR Doc. E5-8225, appearing on page 349,
in the Federal Register of Wednesday, January 4, 2006, the following
correction is made:
1. On page 349, in the third column, the second sentence under
SUPPLEMENTARY INFORMATION is corrected to read: ``This public workshop
is being held in response to the large volume of food labeling
inquiries from small food manufacturers and startups originating from
the area covered by the FDA Dallas District Office.''
Dated: January 9, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-268 Filed 1-12-06; 8:45 am]
BILLING CODE 4160-01-S